Do you have plaque psoriasis?
If so, you may be interested to know that a doctor in your area is conducting a clinical study to assess the safety and effectiveness of a medication in patients with plaque psoriasis. In this study, patients will switch from Enbrel® to the study medication, which is FDA-approved to treat chronic severe plaque psoriasis but has not been studied in psoriasis patients who are switching treatments.
To qualify for participation in this research study, you must:
· Be between the ages of 18 and 75 years old
· Have been diagnosed with plaque psoriasis
· Have been treated with Enbrel® (etanercept) for at least the past 4 months
· Currently have psoriatic lesions
If you qualify and choose to participate in this study, you will receive an initial consultation, study-related examinations, and study medication at no cost to you. Compensation for travel may also be provided.
To learn more, please visit our website at:
Know the five types of psoriasis and how to spot flares.
Newer diabetes treatments can suppress appetite and aid weight loss.
Try these tips to get your salivary glands back into action.
Constipation is a common side effect of opioid and narcotic pain medicines.
Is it sensitive skin or something else?